Novo Nordisk has reported results from its Phase II study of zenagamtide, showing drops in blood sugar and body weight...
The European Commission (EC) has granted marketing authorisation for IntraBio’s Aqneursa to treat neurological symptoms of NPC.The post EC grants...
Onchilles Pharma has dosed the first patient in its Phase I/II clinical trial of N17350 for patients with advanced solid...
GE HealthCare has received 510(k) clearance from the FDA for its AI-powered MIM Contour ProtégéAI+ 2.0 software.The post FDA approves...
Biogen has received the breakthrough therapy designation from the FDA for salanersen (BIIB115), an investigational treatment for SMA.The post Biogen’s...
Insulet has begun distributing an updated version of its Omnipod 5 AID System across the US, following 510(k) clearance in...
J&J has reported that its monoclonal antibody, nipocalimab, met the primary endpoint in the Phase II JASMINE study by reducing...
Regeneron Pharmaceuticals and CytomX have expanded their research and licensing partnership to develop conditionally activated bispecific antibody cancer therapies.The post...
Moonlight Therapeutics has begun the SURVEYOR Phase I clinical trial to assess MOON101, an investigational immunotherapy for peanut allergy.The post...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.